Loading Shopping Cart Items...
Description: Clozapine is the only indicated therapy for Treatment Resistant Schizophrenia but remains underutilized because of the requirement for hematological monitoring. A POC device has been available in Canada since 2019 which allows for real-time monitoring of WBC and ANC from a single drop of finger tip blood. Data will be presented on the device and its application in a community mental health setting in Edmonton, Alberta. POCM is particularly relevant to this population as well as being cost effective, and increases access, safety and positive outcomes.
Start date: Upon registration
Completion: Up to 52 weeks
At the end of this webinar you will be able to:
Speakers: Pierre Chue, MD and Miriane Bouchard BBA Director, Commercialization, In-Vitro Diagnostics
Dr. Chue is a Professor in the Department of Psychiatry at the University of Alberta; Program Lead Complex Psychosis, and Clinical Trials and Research Programs; Consultant Psychiatrist, Addiction and Mental Health, Telemental Health and Community. He is a researcher with the Centre of Excellence for Real World Clinical Outcomes and Neuroscience and Mental Health Institute. Dr. Chue is author or co-author of more than 150 articles and abstracts in peer reviewed medical journals, book chapters, and scientific symposia; he has published several Cochrane Reviews and contributed to national guidelines.
Miriane Bouchard is Director, Commercialization, In-Vitro Diagnostics with HLS and has over 20 years of experience in the diagnostics devices industries. Her extensive experience spans chemistry, immunochemistry, and hematology within international diagnostics corporation to Canadian owned company. Miriane has been an active player in successful product launches and market development of new innovative technologies.
Recorded: May 28, 2023
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...